Medical progress: Cystinosis

New England Journal of Medicine

Volumn 347, Issue 2, 2002, Pages 111-121

  Gahl, William A ^a   Thoene, Jess G ^b   Schneider, Jerry A ^c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTINE; CARRIER PROTEIN; CTNS PROTEIN, HUMAN; GLYCOPROTEIN; MEMBRANE PROTEIN; MERCAPTAMINE;

AMINO ACID SUBSTITUTION; CLINICAL FEATURE; CYSTINOSIS; EARLY DIAGNOSIS; GENE MUTATION; HISTOPATHOLOGY; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT; LYSOSOME; PRIORITY JOURNAL; REVIEW; CHEMISTRY; GENETICS; METABOLISM; MUTATION; PATHOPHYSIOLOGY;

CYSTEAMINE; CYSTINE; CYSTINOSIS; GLYCOPROTEINS; HUMANS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MUTATION;

EID: 0037062909     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra020552     Document Type: Review

References (76)

1. Linkage of the gene for cystinosis to markers on the short arm of chromosome 17
2. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis
3. Familiäre cystindiathese
4. The amino-aciduria in Fanconi syndrome: A study making extensive use of techniques based on paper partition chromatography
5. Cystine storage disease with aminoaciduria and dwarfism (Lignac-Fanconi disease)
6. Cystinosis: A disorder of lysosomal membrane transport
7. Increased cystine in leukocytes from individuals homozygous and heterozygous for cystinosis
8. Increased free-cystine content of fibroblasts cultured from patients with cystinosis
9. Cystine: Compartmentalization within lysosomes in cystinotic leukocytes
10. Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis
11. ATP-dependent lysosomal cystine efflux is defective in cystinosis
12. Binding assays for amino acids: The utilization of a cystine binding protein from Escherichia coli for the determination of acid-soluble cystine in small physiological samples
13. Cadaver renal transplantation in children with cystinosis
14. Cystinosis: Intracellular cystine depletion by aminothiols in vitro and in vivo
15. Cystinosis coming of age
16. A patient with cystinosis presenting with the features of Bartter syndrome
17. Nephrogenic diabetes insipidus, cystinosis, and vitamin D
18. Die veränderungen der nierenfunktion bei der cystinoses. II. Ammosäuren-clearances
19. Cystinosis
20. Medullary nephrocalcinosis in nephropathic cystinosis
21. Survival time in cystinosis: A collaborative study
22. Cysteamine therapy for children with nephropathic cystinosis
23. The course of nephropathic cystinosis after age 10 years
24. Decreased sweat production in cystmosis
25. Neurobehavioral consequences of a genetic metabolic disorder: Visual processing deficits in infantile nephropathic cystinosis
26. Long-term ocular manifestations in nephropathic cystinosis
27. Myopathy and cystine storage in muscles in a patient with nephropathic cystinosis
28. Distal vacuolar myopathy in nephropathic cystinosis
29. Pituitary-testicular function in nephropathic cystinosis
30. Swallowing dysfunction in nephropathic cystinosis
31. Pulmonary dysfunction in adults with nephropathic cystinosis
32. Pancreatic endocrine insufficiency in posttransplant cystinosis
33. Neurologic complications in longstanding nephropathic cystinosis
34. Evidence for cerebral involvement in nephropathic cystinosis
35. Pancreatic exocrine insufficiency in a patient with nephropathic cystinosis
36. Classical nephropathic cystinosis as an adult disease
37. Successful pregnancy despite placental cystine crystals in a woman with nephropathic cystinosis
38. Cystinosis: Combined clinical staff conference at the National Institutes of Health
39. Corneal crystals in nephropathic cystinosis: Natural history and treatment with cysteamine eyedrops
40. Early development of the renal lesions in infantile cystinosis
41. Characteristics of cystine counter-transport in normal and cystinotic lysosome-rich leucocyte granular fractions
42. Lysosomal cystine counter-transport in heterozygotes for cystinosis
43. Disorders of free sialic acid storage
44. +-driven lysosomal cystine transporter
45. The genomic region encompassing the nephropathic cystinosis gene (CTNS): Complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion
46. Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS)
47. Molecular characterization of CTNS deletions in nephropathic cystinosis: Development of a PCR-based detection assay
48. CTNS mutations in an American-based population of cystinosis patients
49. The promoter of a lysosomal membrane transporter gene, CTNS, binds SP-1, shares sequences with the promoter of an adjacent gene, CARKL, and causes cystinosis if mutated in a critical region
50. CTNS mutations in patients with cystinosis
51. Severity of phenotype in cystinosis varies with mutations in the CTNS gene: Predicted effect on the model of cystinosin
52. Cystine: Binding protein assay
53. An improved method for heterozygote detection of cystinosis, using polymorphonuclear leukocytes
54. Prenatal diagnosis of cystinosis
55. Prenatal diagnosis ofcystinosis utilizing chorionic villus sampling
56. Diagnosis of cystinosis with use of placenta
57. Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome
58. Treatment with recombinant human growth hormone in short children with nephropathic cystinosis: No evidence for increased deterioration rate of renal function
59. Renal transplantation for childhood cystinosis
60. Renal homotransplantation in the treatment of cystinosis
61. Improved renal function in children with cystinosis treated with cysteamine
62. Effects of early cysteamme therapy on thyroid function and growth in nephropathic cystinosis
63. Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts: Role in therapeutic cystine removal
64. Adverse reactions to oral cysteamine use in nephropathic cystinosis
65. Developmental toxicity of cysteamine in the rat: Effects on embryo-fetal development
66. Removal of corneal crystals by topical cysteamine in nephropathic cystinosis
67. A randomized placebo-controlled trial of cystearmne eye drops in nephropathic cystinosis
68. Adolescent cystinosis: Comparisons with infantile and adult forms
69. Mutations of CTNS causing intermediate cystinosis
70. Cystinosis in an adult
71. Ocular, nonnephropathic cystinosis: Clinical, biochemical, and molecular correlations
72. Cystinotic fibroblasts display aberrant apoptosis
73. Generation and characterization of a cystinosis murine model